CCP 102: ICI CERVICAL CANCER PRECEPTORSHIP

Multidisciplinary management, standards of care, optimal diagnostics, therapies, and future perspectives in the care of Cervical Cancer patients in sub-Saharan Africa.

Eldoret, Kenya

21st February 2022 – 1st April 2022

Training Duration: 6 weeks

Course Director: Prof. Fredrick Chite Asirwa MD
Consultant Physician. Medical Oncologist & Hematologist
Executive Director/CEO: International Cancer Institute (ICI)
P.O. Box 8088, Code 30100 Eldoret, Kenya
Email: director@intercancer.com Website: www.intercancer.com

Lead Course Faculty:
Dr. Kevin Makori MD, MMED
Clinical & Radiation Oncologist
Deputy Director of Programs
International Cancer Institute (ICI)
P.O. Box 8088, Code 30100 Eldoret, Kenya
Email: kevin.makori@intercancer.com Website: www.intercancer.com

This educational activity is provided by International Cancer Institute (ICI) through the Blueprint Program

Accreditation of this course is by KMPDC, PPB, NCK, and COC

Target Audience

The primary target audience for this course comprises the multidisciplinary clinical cancer care team members including, but not limited to medical, surgical, and radiation oncologists; fellows; gastroenterologists; nephrologists; neurologists; pathologists; pulmonologists; radiologists; researchers; oncology nurse practitioners and oncology nurses; Oncology pharmacists; Oncology Pharm Techs; Oncology clinical officers; physician assistants; and other allied health care professionals.

Statement of Need

General internists and Primary Care Clinicians must maintain an extensive knowledge base on a wide variety of topics covering all body systems as well as common and uncommon disorders. International Cancer Institute’s Preceptorship Courses aims to leverage the expertise of its Faculty to help clinicians understand best practices in diagnosis and management of conditions encountered in the clinical setting in sub-Saharan Africa.

LEARNING OBJECTIVES

At the end of this educational activity, participants should be able to:

1. Recognize the global burden of cervical cancer and compare its incidence in more and less developed regions

2. describe the epidemiology, etiology, and methods of prevention (including the role of HPV) of cervicalcancer and management of pre-malignant lesions.

3. recognize the role of pathological diagnosis and staging procedures/studies-including diagnostic and radiological procedures for cervical cancer

4. To understand the role of surgery in the management of cervical cancer

5. To understand the role of radiotherapy in the management of cervical cancer

6. Appreciate the Management of locally advanced cervical cancer

7. appreciate the role of systemic therapies, including antiangiogenic therapy in cervical cancer treatment as part of the standard of care treatment protocols

8. recall the goals and standard of care in the management of metastatic cervical cancer.

9. understand the role of Palliative, supportive, and survivorship care in cervical cancer management

10. To discuss clinical cases between faculty and participants

Disclosure of Conflicts of Interest

International Cancer Institute (ICI) requires instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or the apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ICI for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care
recommendations.

The faculty must report any financial relationships or contractual relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Method of Participation and Request for Credit

To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures, and actively participate in the educational activity. Upon successfully completing the post-test with a score of 75% or better and the post-activity evaluation, your certificate will be made available immediately.

The Program

LECTURES

1. Orientation to the course (Chite) Monday 21st Feb 2022 3:30-4:00 PM EAT

2. Epidemiology of cervical cancer in sub-Saharan Africa vs Global burden (Muluken) Monday 21st Feb 2022 4:00 – 4:30 PM EAT

3. Cervical Cancer Prevention & management of pre-malignant lesions (Elly) Wednesday 23rd Feb 2022 4:00-5:30 PM EAT

4. Pathological diagnostics and pathology interpretation in cervical Cancer (Kibet) Monday 28th Feb 2022 4:00-5:30 PM EAT

5. The role of surgery in cervical cancer management (Ganda) Wednesday 2nd Mar 2022 4:00-5:30 PM EAT

6. Staging in cervical cancer (Siwillis) Monday 7th Mar 2022 4:00-5:30 PM EAT

7. Management of Early-stage Cervical Cancer (Dawit) Wednesday 9th Mar 2022 4:00-5:30 PM EAT

8. Management of locally advanced cervical cancer (Verna) Monday 14th Mar 2022 4:00-5:30 PM EAT

9. Public Health perspectives in the Prevention and control of cervical cancer (Chilwesa) Wednesday 16th Mar 2022 4:00-5:30 PM EAT

10. Management of Metastatic or Recurrent Cervical Cancer (Makori) Monday 21st Mar 2022 4:00-5:30 PM EAT

11. Supportive, Palliative and Survivorship care in cervical Cancer Care (Hussein) Wed 23rd Mar 2022 4:00-5:30 PM EAT

12. Research priorities & clinical trial opportunities in cervical cancer in SSA (Chite) Mon 28th Mar 2022 4.00 – 5.30 PM EAT

13. End of course examination (Education office) Friday 1st Apr 2022 4:00-5:30 PM EAT

CCP 101: ICI Cervical Cancer Preceptorship Course Schedule

Participants should be willing to spend at least 4 hours per week on this online course over a period of 6 weeks. (Duration 24 hours). This program will start when the class is fully subscribed. The course cost is $200.00 for the entire course. There are few sponsorships available on a first-come basis for those who apply. Priority will be given to those working in cancer centers that have formal affiliations/Partnerships with the International Cancer Institute. Apply for sponsorship during the registration of the course.

All those interested in registering for this course, please register your information on www.elearning.intercancer.com if you have any questions or queries please send an email to

education@intercancer.com or director@intercancer.co

For more information visit our website

www.intercancer.com

International Cancer Institute (ICI) ©2022

Your Partner in Cancer Control in SSA